Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 79.5T | 83.4T | 84.6T | 86.4T |
Cost of revenue | 61.7T | 66.3T | 65.7T | 67.3T |
Gross profit | 17.8T | 17.1T | 18.9T | 19.1T |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 7.8T | 7.8T | 8.5T | 8.1T |
Other operating expenses | — | — | — | — |
Operating income | 9.9T | 9.2T | 10.4T | 10.9T |
Non operating interest income | ||||
Income | 935B | 856B | 856B | 892B |
Expense | 957B | 921B | 868B | 959B |
Other income expense | — | — | — | — |
Pretax income | 13.4T | 10.6T | 12.4T | 15.8T |
Tax provision | 2.4T | 2.1T | 2.4T | 2.8T |
Net income | 10.9T | 8.6T | 10.0T | 13.0T |
Basic EPS | — | 171 | — | — |
Diluted EPS | — | 171 | — | — |
Basic average shares | — | 40.5B | — | — |
Diluted average shares | — | 40.5B | — | — |
EBITDA | 14.3T | 11.9T | 13.4T | 16.0T |
Net income from continuing op. | — | — | — | — |
Minority interests | -2.3T | -1.6T | -1.8T | -3.0T |
Preferred stock dividends | 0 | 0 | 0 | 0 |